Novozymes A/S (OTCMKTS:NVZMY) Sees Strong Trading Volume - Should You Buy?

Key Points

• Trading spike: Shares experienced unusually high volume—about 136,923 shares traded, a 40% increase from the prior session—and the stock was up roughly 2.3% at $58.61.
• Earnings miss: The company reported quarterly EPS of $0.35 versus $0.79 expected and revenue of $1.18B versus $1.22B consensus, a notable shortfall.
• Valuation & balance sheet: Market cap is about $24.4B with a P/E of 42.1 and PEG of 1.03; debt-to-equity is low at 0.12 but the current ratio is below 1 at 0.72, indicating tight short-term liquidity.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 136,923 shares changed hands during trading, an increase of 40% from the previous session's volume of 97,533 shares.The stock last traded at $58.61 and had previously closed at $57.65.

Novozymes A/S Trading Up 2.3%

The company has a 50 day moving average of $59.44 and a 200 day moving average of $61.48. The firm has a market cap of $24.44 billion, a P/E ratio of 42.11, a PEG ratio of 1.03 and a beta of 1.11. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.00 and a current ratio of 0.72.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.79 by ($0.44). The business had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.22 billion. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.37%. Analysts predict that Novozymes A/S will post 1.82 EPS for the current fiscal year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company's product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.